I agree. I think sometimes investors that are here look for him when expected developments, as Joe himself gave guidance for in the conference calls, don’t materialize near the corporate guided timelines. Besides acquisitions noted over numerous conference calls that we await, are the funding mentioned dating back to when Generex was talking of sponsoring clinical trials for pharma. That endeavor no longer appears part of their plan, but concrete funding as mentioned quarter after quarter eventually must be noted in a 8k. Forward looking talk on a call or in a forum is great, but hopefully we actually see that progress in a filing.